MedTrace Logo

Efficacy of Two Vaginal Solutions in Preoperative Use

NCT03014778 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-02-28

No results posted yet for this study

Summary

This study is necessary in order to provide proof the effectiveness of Chlorhexidine gluconate and its safety.

Conditions

  • Vaginal Surgeries

Interventions

DRUG

The Chlorhexidine gluconate 0.05%

Washing vagina pre- operatively with Chlorhexidine gluconate 0.05%

DRUG

10% Povidone iodine

Washing vagina pre- operatively with 10% Povidone iodine

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Principal Investigators

  • Sharon Tzemah, MD · Haemek MC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-12-31
Completion
2019-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014778 on ClinicalTrials.gov